Deutsche Bank
NDRM

Deutsche Bank’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Deutsche Bank’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,300
Closed -$2.62M – 5386
2017
Q3 		$2.62M Buy
67,300
+57,799
+608% +$2.13M ﹤0.01% 2364
2017
Q2 		$283K Sell
9,501
-23,180
-71% -$600K ﹤0.01% 3749
2017
Q1 		$866K Sell
32,681
-24,595
-43% -$609K ﹤0.01% 2751
2016
Q4 		$1.27M Buy
57,276
+49,912
+678% +$934K ﹤0.01% 2539
2016
Q3 		$136K Sell
7,364
-4,701
-39% -$81.5K ﹤0.01% 3820
2016
Q2 		$195K Buy
12,065
+4,215
+54% +$71K ﹤0.01% 3789
2016
Q1 		$110K Sell
7,850
-20,783
-73% -$281K ﹤0.01% 3959
2015
Q4 		$488K Buy
+28,633
New +$558K ﹤0.01% 3285
2015
Q3 		– Sell
-300
Closed -$4K – 5642
2015
Q2 		$4K Buy
+300
New +$4.22K ﹤0.01% 5194
2015
Q1 		– Sell
-8,929
Closed -$125K – 6568
2014
Q4 		$125K Buy
+8,929
New +$70.6K ﹤0.01% 4579

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Deutsche Bank's NDRM Position: Q4 2017 in Review

Deutsche Bank sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 67,300 shares — an estimated $2.62M sold.

Deutsche Bank first reported a position in NDRM in Q4 2014 and held it in 10 quarters. The position peaked at $2.62M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Deutsche Bank reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Deutsche Bank sold 67,300 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $2.62M.
  • Deutsche Bank first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2014 and held it in 10 quarters.
  • Deutsche Bank's NeuroDerm Ltd. Ordinary Shares position peaked at $2.62M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.